PT-141 Dosage Chart
What is the ideal dosage of PT-141 to maintain sexual health? This depends on the individual needs of the person taking this medication; hence, it is always recommended that you get PT-141 via a prescription from a qualified doctor who specializes in urology and men’s health. This is to ensure that you are not taking a dose of the drug that is too low or too high.
The very first time PT-141 was experimented on (as melanotan II), the dose was 10 mg. For some subjects this caused a long-lasting erection. Hence, researchers have lowered the dose in the hopes of achieving a more modest response. At about 1.25 mg, an erection can be achieved upon additional sexual stimuli.
Since then, scientists have researched the properties of PT-141 at various doses. For example, one clinical trial investigated the properties of PT-141 between 0 mg (placebo) to 10 mg. The route of administration in this study was intranasal (through the nose).
The LOVER Protocol by Maximus contains PT-141 at a dose of 2000 mcg. Crucially, it also contains tadalafil 5 mg. This allows PT-141 to work synergistically with tadalafil to help you develop and maintain erections.
The LOVER Protocol also differs from typically available PT-141 in that it is packaged in the form of a tablet. It is orally dissolved and fast-acting. This means no nasty injections that can give you swelling or bruising.
In addition, the LOVER Protocol is meant to promote sexual health in general. This means that it is not to be taken only before a sexual encounter, but on a regular basis.
The LOVER Protocol by Maximus contains PT-141 2000 mcg and tadalafil 5 mg. It is intended to boost your sexual health and performance for the immediate and longterm.
References
Hadley ME. Discovery that a melanocortin regulates sexual functions in male and female humans. Peptides. 2005;26(10):1687-1689. doi:10.1016/j.peptides.2005.01.023
Rosen RC, Diamond LE, Earle DC, Shadiack AM, Molinoff PB. Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra. Int J Impot Res. 2004;16(2):135-142. doi:10.1038/sj.ijir.3901200
